Advertisement

Ampulla of Vater and Head of Pancreas Carcinomas

  • Paul J. KellyEmail author
Chapter
  • 34 Downloads

Abstract

Ampulla of Vater and Head of Pancreas Carcinomas: this chapter outlines the incidence, risk factors, clinical presentation, investigations, treatments and prognosis of cancer at this anatomical site. These features are correlated with the core data that are required to make the corresponding histopathology reports of a consistently high quality, available in an appropriate timeframe, and clinically relevant to patient management and prognosis. Summary details of the common cancers given at this site include: gross description, histological types, tumour grade/differentiation, extent of local tumour spread, lymphovascular invasion, lymph node involvement, and the status of excision margins. Current WHO Classifications of tumours and TNM8 are referenced. Notes are provided on other associated pathology, contemporary use of immunohistochemistry, updates on the role of evolving molecular tests, and the use of these ancillary techniques as biomarkers in diagnosis, and prediction of prognosis and treatment response. A summary is given of the more common non-carcinoma malignancies that are encountered at this site in diagnostic practice.

Keywords

Pancreatic carcinoma Pancreatic neuroendocrine neoplasms Intraductal papillary neoplasms Exocrine tumours Grading Immunophenotype Neoadjuvant effects 

Bibliography

  1. Bond-Smith G, Banga N, Hammond TM, Imber CJ. Pancreatic adenocarcinoma. BMJ. 2012;344:45–50.CrossRefGoogle Scholar
  2. Bosman FT, Carneiro F. GI WHO classification of tumours. Digestive system tumours. 5th ed.; 2019.Google Scholar
  3. British Society of Gastroenterology. Guidelines for the management of patients with pancreatic cancer, periampullary and ampullary carcinomas. Gut. 2005;54:v1–v15.CrossRefGoogle Scholar
  4. Campbell F, Verbeke CS. Pathology of the pancreas. A practical approach, 2013. Springer.-Verlag. London. Google Scholar
  5. Carter D, Russell RCG, Pitt HA, Bismuth H, editors. Rob and Smith’s operative surgery: hepatobiliary and pancreatic surgery. 5th ed. London: Chapman and Hall; 1996.Google Scholar
  6. Esposito I, Konukiewitz B, Schlitter AM, Kloppel G. Pathology of pancreatic ductal adenocarcinoma: facts, challenges and future developments. World J Gastroenterol. 2014;20:13833–41.CrossRefGoogle Scholar
  7. Falconi M, Eriksson B, Kaltsas G, et al. ENETS consensus guidelines update for the management of patients with functional pancreatic neuroendocrine tumors and non-functional pancreatic neuroendocrine tumors. Neuroendocrinology. 2016;103:153–71.CrossRefGoogle Scholar
  8. Garcia-Carbonero R, Sorbye H, Baudin E, et al. ENETS consensus guidelines for high-grade gastroenteropancreatic neuroendocrine tumors and neuroendocrine carcinomas. Neuroendocrinology. 2016;103:186–94.CrossRefGoogle Scholar
  9. Haugk B. Pancreatic intraepithelial neoplasia – can we detect early pancreatic cancer? Histopathology. 2010;57:503–14.CrossRefGoogle Scholar
  10. Hruban RH, Pitman MB, Klimstra DS. Tumors of the pancreas. In: Atlas of tumor pathology. 4th ed.. Fascicle 6. Washington: AFIP; 2007.Google Scholar
  11. Hong SM, Park JY, Hruban RH, Goggins M. Molecular signatures of pancreatic cancer. Arch Pathol Lab Med. 2011;135:716–27.PubMedPubMedCentralGoogle Scholar
  12. Jun SY, Hong SM. Nonductal pancreatic cancers. Surg Pathol Clin. 2016;9:581–93.CrossRefGoogle Scholar
  13. Kamisawa T, Wood LD, Itoi T, Takaori K. Pancreatic cancer. Lancet. 2016;388:73–85.Google Scholar
  14. Lloyd RV, Osamura RY, Kloppel G, et al. WHO classification of tumours of endocrine organs. 4th ed. Lyon: World Health Organization Classification of Tumours. International Agency for Research on Cancer (IARC); 2017.Google Scholar
  15. Luchini C, Capelli P, Scarpa A. Pancreatic ductal adenocarcinoma and its variants. Surg Pathol Clin. 2016;9:547–60.CrossRefGoogle Scholar
  16. McGuigan A, Kelly P, Turkington RC, Jones C, Coleman HG, McCain RS. Pancreatic cancer: a review of clinical diagnosis, epidemiology, treatment and outcomes. World J Gastroenterol. 2018;24:4846–61.CrossRefGoogle Scholar
  17. O’Reilly D, Fou L, Hasler E, et al. Diagnosis and management of pancreatic cancer in adults: a summary of guidelines from the UK National Institute for health and care excellence. Pancreatology. 2018;18:962–70.CrossRefGoogle Scholar
  18. Ramage JK, Ahmed A, Ardill J, et al. Guidelines for the management of gastroenteropancreatic neuroendocrine including carcinoid tumours (NETs). Gut. 2012;61:6–32.CrossRefGoogle Scholar
  19. Reid MD, Saka B, Balci S, Goldblum AS, Adsay NV. Molecular genetics of pancreatic neoplasms and their morphologic correlates: an update on recent advances and potential diagnostic applications. Am J Clin Pathol. 2014;141:168–80.CrossRefGoogle Scholar
  20. The Royal College of Pathologists. Cancer Datasets (Oesophageal Carcinoma, Gastric Carcinoma, Carcinomas of the Pancreas, ampulla of Vater and Common Bile Duct, Colorectal Cancer, Gastrointestinal Stromal Tumours (GISTs), Liver Resection Specimens and Liver Biopsies for Primary and Metastatic Carcinoma, Endocrine Tumours of the Gastrointestinal Tract including Pancreas) and Tissue Pathways (Gastrointestinal and Pancreatobiliary Pathology, Liver Biopsies for the Investigation of Medical Disease and for Focal Liver Lesions). Accessed at https://www.rcpath.org/profession/guidelines/cancer-datasets-and-tissue-pathways.html
  21. Verbeke CS. Resection margins in pancreatic cancer. Surg Clin North Am. 2013;93:647–62.CrossRefGoogle Scholar
  22. Verbeke CS, Knapp J, Gladhaug IP. Tumour growth is more dispersed in pancreatic head cancers than in rectal cancer: implications for resection margin assessment. Histopathology. 2011;59:1111–21.CrossRefGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2020

Authors and Affiliations

  1. 1.Institute of Pathology, Royal Victoria HospitalBelfastUK

Personalised recommendations